Skip to content

Usefulness of BiClamp Forceps for Liver Resection: A Randomized Clinical Trial

BiClamp Forceps Liver Transection Versus Clamp Crushing Technique in Liver Resections: A Randomized Clinical Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02197481
Enrollment
105
Registered
2014-07-22
Start date
2014-09-30
Completion date
2016-05-31
Last updated
2017-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatobiliary Disease

Keywords

BiClamp forceps hepatectomy, Clamp crushing technique, Liver parenchyma transection, Randomized controlled trial

Brief summary

The purpose of this study is to compare short-term and long-term efficacy of BiClamp forceps hepatectomy and clamp-crushing technique for parenchymal transection during elective hepatic resection.

Detailed description

Background: Blood loss and the need for blood transfusions during the liver transection have shown to be correlated with higher morbidity and mortality rates and with worsen prognosis. Various devices of liver parenchymal transection have been developed with a view to reducing the intraoperative blood loss. However, to the present there is no randomized controlled trial evaluating the technique of BiClamp forceps during the liver transection. The goal of the present study was to evaluate the safety and effectiveness of BiClamp forceps transection in comparison to the clamp crushing technique in patients offered liver resection. Intervention: One hundred patients with hepatobiliary disease need undergo hepatectomy at Anhui medical university were selected and divided into BiClamp forceps hepatectomy group and clamp-crushing hepatectomy group, each group contains 50 cases. Results: 1. Clinical data include: blood loss during liver transection, total blood loss, blood transfusion, hospital stay, morbidity, mortality, biliary leakage, postoperative liver function, liver transection time, operation time, resection margins, need for portal trial clamping. 2. Statistical method: groups t-test, univariate/multivariate analysis, logistic regression analysis, mixed linear regression and Cox survival analysis were used.

Interventions

PROCEDUREClamp-Crushing technique

Liver transection during hepatectomy by monopole electronicknife and blood vessel forceps, but without BiClamp forceps

DEVICEBiClamp forceps

liver transection during hepatectomy by BiClamp forceps

Sponsors

The First Affiliated Hospital of Anhui Medical University
CollaboratorOTHER
The Second Hospital of Anhui Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Both male and female, aged 18 or older * Patients scheduled to undergo hepatic resection for some benign or malignant hepatobiliary disease * Child-Pugh class A or B liver function * BiClamp forceps hepatectomy and clamp-crushing feasible based on preoperative imaging * No tumor invasion the main vein, hepatic artery and vein and major inferior vena cava * No extrahepatic metastasis * Voluntary participation in the study, and informed consent.

Exclusion criteria

* Age \<18 years or\> 65 years , pregnant or lactating women * Preoperative liver function evaluation: Child-Pugh C grade * Laparoscopic hepatectomy * Extrahepatic metastasis * Tumor invasion the main vein, hepatic artery and vein and major inferior vena cava * The patient refused to sign the informed consent form

Design outcomes

Primary

MeasureTime frameDescription
The Total Blood Lossan expected average of 80 minutesBlood loss during operation. Blood loss was calculated from the beginning to the end of operation The amount of blood loss was measured from the suction volume after subtraction of rinse fluids and from the weight of soaked gauzes that were used during transection

Secondary

MeasureTime frameDescription
Mortality90 daysOperative mortality was defined as any death resulting from a complication during surgery
Morbidity90 days
Biliary Leakage90 daysBiliary leakage was documented in line with the International Study Group of Liver Surgery (ISGLS) definitions and grading systems
Liver Transection Timean expected average of 40 minutesliver transection time was calculated from the beginning to the end of the liver resection
Number of Participants Requiring a Blood Transfusion2 daysAdministration of blood transfusions is documented for the intraoperative and postoperative period until 48 hours postoperatively
Total Bilirubin3 postoperative dayserum total bilirubin on 3 postoperative day (umol/L)
Duration of Postoperative Hospital Stayan expected average of 12 daysTime from day of operation to day of discharge

Countries

China

Participant flow

Recruitment details

Eligibility criteria included scheduled liver resection for benign or malignant hepatobiliary disease and a minimum age of 18 years.

Pre-assignment details

Patients undergoing concomitant vascular resection or bile duct resection and those undergoing emergency liver resection were excluded.

Participants by arm

ArmCount
Clamp-Crushing Technique
liver transection during hepatectomy by the routine clamp-crushing technical without BiClamp forceps assisted Clamp-Crushing technique: Liver transection during hepatectomy by monopole electronicknife and blood vessel forceps, but without BiClamp forceps
43
BiClamp Forceps Hepatectomy
The BiClamp forceps, a reusable bipolar sealing instrument for use in open surgery, was uniformly employed in all patients randomized to BiClamp forcep hepatectomy group in the present study. BiClamp forceps: liver transection during hepatectomy by BiClamp forceps
43
Total86

Baseline characteristics

CharacteristicClamp-Crushing TechniqueBiClamp Forceps HepatectomyTotal
Age, Continuous53.12 years
STANDARD_DEVIATION 10.84
55.98 years
STANDARD_DEVIATION 11.3
54.55 years
STANDARD_DEVIATION 11.1
Region of Enrollment
China
43 participants43 participants86 participants
Sex: Female, Male
Female
16 Participants23 Participants39 Participants
Sex: Female, Male
Male
27 Participants20 Participants47 Participants
Specimen weight230.73 g
STANDARD_DEVIATION 191.35
193.25 g
STANDARD_DEVIATION 182.48
211.99 g
STANDARD_DEVIATION 186.82
Transection surface area69.11 cm2
STANDARD_DEVIATION 40.09
65.16 cm2
STANDARD_DEVIATION 44.3
67.14 cm2
STANDARD_DEVIATION 42.04

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
12 / 4312 / 43
serious
Total, serious adverse events
4 / 432 / 43

Outcome results

Primary

The Total Blood Loss

Blood loss during operation. Blood loss was calculated from the beginning to the end of operation The amount of blood loss was measured from the suction volume after subtraction of rinse fluids and from the weight of soaked gauzes that were used during transection

Time frame: an expected average of 80 minutes

ArmMeasureValue (MEAN)Dispersion
Clamp-Crushing TechniqueThe Total Blood Loss376.73 mlStandard Deviation 303.67
BiClamp Forceps HepatectomyThe Total Blood Loss339.81 mlStandard Deviation 257.2
Secondary

Biliary Leakage

Biliary leakage was documented in line with the International Study Group of Liver Surgery (ISGLS) definitions and grading systems

Time frame: 90 days

ArmMeasureValue (NUMBER)
Clamp-Crushing TechniqueBiliary Leakage4 participants
BiClamp Forceps HepatectomyBiliary Leakage2 participants
Secondary

Duration of Postoperative Hospital Stay

Time from day of operation to day of discharge

Time frame: an expected average of 12 days

ArmMeasureValue (MEAN)Dispersion
Clamp-Crushing TechniqueDuration of Postoperative Hospital Stay8.65 daysStandard Deviation 2.02
BiClamp Forceps HepatectomyDuration of Postoperative Hospital Stay8.81 daysStandard Deviation 2.49
Secondary

Liver Transection Time

liver transection time was calculated from the beginning to the end of the liver resection

Time frame: an expected average of 40 minutes

ArmMeasureValue (MEAN)Dispersion
Clamp-Crushing TechniqueLiver Transection Time25.51 minStandard Deviation 12.19
BiClamp Forceps HepatectomyLiver Transection Time26.21 minStandard Deviation 17.17
Secondary

Morbidity

Time frame: 90 days

ArmMeasureValue (NUMBER)
Clamp-Crushing TechniqueMorbidity13 participants
BiClamp Forceps HepatectomyMorbidity12 participants
Secondary

Mortality

Operative mortality was defined as any death resulting from a complication during surgery

Time frame: 90 days

ArmMeasureValue (NUMBER)
Clamp-Crushing TechniqueMortality0 participants
BiClamp Forceps HepatectomyMortality0 participants
Secondary

Number of Participants Requiring a Blood Transfusion

Administration of blood transfusions is documented for the intraoperative and postoperative period until 48 hours postoperatively

Time frame: 2 days

ArmMeasureValue (NUMBER)
Clamp-Crushing TechniqueNumber of Participants Requiring a Blood Transfusion2 participants
BiClamp Forceps HepatectomyNumber of Participants Requiring a Blood Transfusion4 participants
Secondary

Total Bilirubin

serum total bilirubin on 3 postoperative day (umol/L)

Time frame: 3 postoperative day

ArmMeasureValue (MEAN)Dispersion
Clamp-Crushing TechniqueTotal Bilirubin17.70 umol/lStandard Deviation 11.34
BiClamp Forceps HepatectomyTotal Bilirubin18.46 umol/lStandard Deviation 17.75

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026